Do self-reports of perceptual anomalies reflect gating deficits in schizophrenia patients?

Biological Psychiatry

Volumn 47, Issue 5, 2000, Pages 463-467

  Light, Gregory A ^a   Braff, David L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Event related potential; Gating; Neuropsychology; P50; Schizophrenia; Suppression

Indexed keywords

AWARENESS; COGNITION; COGNITIVE DEFECT; EVENT RELATED POTENTIAL; HUMAN; PERCEPTION DISORDER; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA;

ATTENTION; EVOKED POTENTIALS, AUDITORY; HUMANS; PERCEPTUAL DISORDERS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SELF ASSESSMENT (PSYCHOLOGY); SELF DISCLOSURE;

EID: 0033955227     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(99)00280-2     Document Type: Review

References (43)

1. Adler L.E., Pachtman E., Franks R.D., Pecevich M., Waldo M.C., Freedman R. Neurophysiological evidence for a defect in neuronal mechanisms involved in sensory gating in schizophrenia. Biol Psychiatry. 17:1982;639-654.
2. Adler L.E., Waldo M.C., Tatcher A., Cawthra E., Baker N., Freedman R. Lack of relationship of auditory gating defects to negative symptoms in schizophrenia. Schizophr Res. 3:1990;131-138.
3. Alexopoulos G.S. Lack of complaints in schizophrenics with tardive dyskinesia. J Nerv Ment Dis. 167:1979;125-127.
4. Amador X.F., Flaum M., Andreasen N.C., Strauss D.H., Yale S.A., Clark S.C., Gorman J.M. Awareness of illness in schizophrenia and schizoaffective and mood disorders. Arch Gen Psychiatry. 51:1994;826-836.
5. Amador X.F., Strauss D.H., Yale S.A., Flaum M.M., Endicott J., Gorman J.M. Assessment of insight in psychosis. Am J Psychiatry. 150:1993;873-879.
6. Anderson S.W., Tranel D. Awareness of disease states following cerebral infarction, dementia, and head trauma Standardized assessment . Clin Neuropsychol. 3:1989;327-339.
7. Andreasen N.C. Scale for the Assessment of Negative Symptoms (SANS). 1984;University of Iowa, Iowa City.
8. Arango C., Adami H., Sherr J.D., Thaker G.K., Carpenter W.T. Jr. Relationship of awareness of dyskinesia in schizophrenia to insight into mental illness. Am J Psychiatry. 156:1999;1097-1099.
9. Blackwood D.H., Whalley L.J., Christie J.E., Blackburn I.M., St. Clair D.M., McInnes A. Changes in auditory P3 event-related potential in schizophrenia and depression. Br J Psychiatry. 150:1987;154-160.
10. Bleuler E., Aschaffenburg G. Dementia praecox, oder Gruppe der Schizophrenien. 1911;F. Deuticke, Leipzig, Germany.
11. Braff D.L. Psychophysiological and information processing approaches to schizophrenia. Charney D.S., Nestler E., Bunney B.S. Neurobiological Foundation of Mental Illness. 1999;258-271 Oxford University Press, New York.
12. Braff D.L., Geyer M.A. Sensorimotor gating and schizophrenia. Human and animal model studies. Arch Gen Psychiatry. 47:1990;181-188.
13. Bunney W.E. Jr, Hetrick W.P., Bunney B.G., Patterson J.V., Jin Y., Potkin S.G., Sandman C.A. Structured Interview for Assessing Perceptual Anomalies (SIAPA). Schizophr Bull. 25:1999;577-592.
14. Butler R.W., Braff D.L. Delusions A review and integration . Schizophr Bull. 17:1991;633-647.
15. Callaway E., Naghdi S. An information processing model for schizophrenia. Arch Gen Psychiatry. 39:1982;339-347.
16. Carpenter W.T. Jr, Strauss J.S., Bartko J.J. Flexible system for the diagnosis of schizophrenia Report from the WHO International Pilot Study of Schizophrenia . Science. 182:1973;1275-1278.
17. Chelune G.J., Heaton R.K., Lehman R.A.W. Neuropsychological and personality correlates of patients' complaints of disability. Adv Clin Neuropsychol. 3:1986;95-126.
18. Cullum C.M., Harris J.G., Waldo M.C., Smernoff E., Madison A., Nagamoto H.T., et al. Neurophysiological and neuropsychological evidence for attentional dysfunction in schizophrenia. Schizophr Res. 10:1993;131-141.
19. Eccles J.C. The Inhibitory Pathways of the Central Nervous System. 1969;Charles C Thomas, Springfield, IL.
20. Erwin R.J., Turetsky B.I., Moberg P., Gur R.C., Gur R.E. P50 abnormalities in schizophrenia relationship to clinical and neuropsychological indices of attention . Schizophr Res. 33:1998;157-167.
21. Ford J.M., White P.M., Csernansky J.G., Faustman W.O., Roth W.T., Pfefferbaum A. ERPs in schizophrenia Effects of antipsychotic medication . Biol Psychiatry. 36:1994;153-170.
22. Freedman R., Adler L.E., Waldo M.C., Pachtman E., Franks R.D. Neurophysiological evidence for a defect in inhibitory pathways in schizophrenia Comparison of medicated and drug-free patients . Biol Psychiatry. 18:1983;537-551.
23. Hirayasu Y., Asato N., Ohta H., Hokama H., Arakaki H., Ogura C. Abnormalities of auditory event-related potentials in schizophrenia prior to treatment. Biol Psychiatry. 43:1998;244-253.
24. Jin Y., Bunney W.E. Jr, Sandman C.A., Patterson J.V., Fleming K., Moenter J.R., et al. Is P50 suppression a measure of sensory gating in schizophrenia? Biol Psychiatry. 43:1998;873-878.
25. Kihlstrom J.F., Hoyt I.P. Hypnosis and the psychology of delusions. Oltmanns T.F., Maher B.A. Delusional Beliefs. 1988;66-109 Wiley, New York.
26. Light GA, Geyer MA, Clementz BA, Cadenhead KS, Braff DL (in press): Schizophrenia patients treated with atypical antipsychotic medications have "normal" P50 suppression. Am J Psychiatry.
27. Lin I.F., Spiga R., Fortsch W. Insight and adherence to medication in chronic schizophrenics. J Clin Psychol. 40:1979;430-432.
28. McGhie A., Chapman J. Disorders of attention and perception in early schizophrenia. Br J Med Psychol. 34:1961;103-116.
29. McGlynn S.M., Kaszniak A.W. Unawareness of deficits in dementia and schizophrenia. Prigatano G.P., Schacter D.L. Awareness of Deficit after Brain Injury Clinical and Theoretical Issues . 1991;84-110 Oxford University Press, New York.
30. McGlynn S.M., Kaszniak A.W. When metacognition fails Impaired awareness of deficit in Alzheimer's disease . J Cogn Neurosci. 3:1991;183-189.
31. McGlynn S.M., Schacter D.L. Unawareness of deficits in neuropsychological syndromes. J Clin Exp Neuropsychol. 11:1989;143-205.
32. McGlynn S.M., Schacter D.L. The neuropsychology of insight Impaired awareness of deficits in a psychiatric context . Psychiatr Ann. 27:1997;806-811.
33. Nagamoto H.T., Adler L.E., Hea R.A., Griffith J.M., McRae K.A., Freedman R. Gating of auditory P50 in schizophrenics Unique effects of clozapine . Biol Psychiatry. 40:1996;181-188.
34. Nagamoto H.T., Adler L.E., McRae K.A., Huettl P., Cawthra E., Gerhardt G., et al. Auditory P50 in schizophrenics on clozapine Improved gating parallels clinical improvement and changes in plasma 3-methoxy-4-hydroxyphenylglycol . Neuropsychobiology. 39:1999;10-17.
35. Pallanti S., Quercioli L., Pazzagli A. Effects of clozapine on awareness of illness and cognition in schizophrenia. Psychiatry Res. 86:1999;239-249.
36. Reisberg B., Gordon B., McCarthy M., Ferris S.H. Clinical symptoms accompanying progressive decline and Alzheimer's disease. Melnick V.L., Dubler N.N. Alzheimer's Dementia. 1985;19-39 Humana Press, Clifton, NJ.
37. Schneck M.K., Reisberg B., Ferris S.H. An overview of current concepts of Alzheimer's disease. Am J Psychiatry. 139:1982;165-173.
38. Smith J.M., Kucharski L.T., Oswald W.T., Waterman L.J. A systematic investigation of tardive dyskinesia in inpatients. Am J Psychiatry. 136:1979;918-922.
39. Van Putten T., Crumpton E., Yale C. Drug refusal in schizophrenia and the wish to be crazy. Arch Gen Psychiatry. 33:1976;1443-1446.
40. Venables P. Selectivity of attention in schizophrenia. Maher B. Progress in Experimental Personality Research. 1964;1-47 Academic Press, New York. Vol 1.
41. Yee C.M., Nuechterlein K.H., Morris S.E., White P.M. P50 suppression in recent-onset schizophrenia Clinical correlates and risperidone effects . J Abnorm Psychol. 107:1998;691-698.
42. Young D.A., Davila R., Scher H. Unawareness of illness and neuropsychological performance in chronic schizophrenia. Schizophr Res. 10:1993;117-124.
43. Zec R.F. Neuropsychological functioning in Alzheimer's disease. Parks R.W., Zec R.F., Wilson R.S. Neuropsychology of Alzheimer's Disease and Other Dementias. 1993;3-80 Oxford University Press, New York.